The study was designed to evaluate the feasibility and safety of hypofractionated whole-breast irradiation with simultaneously integrated boost for early-stage breast cancer after breast conserving surgery in Chinese population.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
200
deliver 40Gy/15Fx to whole breast with 48Gy/15fx simultaneously integrated to tumor bed
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
RECRUITINGNumbers of participants with treatment-related toxicity assessed by CTCAE v4.0
acute toxicity related to irradiation such as lung and skin
Time frame: 2 year
acute radiation-induced toxicity assessed by CTCAE v4.0
acute toxicity related to skin and lung
Time frame: during radiotherapy; 3months; 6 months
local-regional recurrence
Time frame: 5 years
Disease free survival
Time frame: 5 years
Overall survival Over survival
Time frame: 5 years
Late complications
Time frame: 1,2,3,4,5years
cosmetic effect measured by Harvard 4 scale evaluation system
Time frame: 2,3,4,5years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.